ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $496,531 | +182.1% | 12,526 | +35.6% | 0.00% | – |
Q4 2023 | $176,038 | +118.5% | 9,236 | +31.3% | 0.00% | – |
Q3 2023 | $80,551 | -38.2% | 7,035 | -44.5% | 0.00% | – |
Q2 2023 | $130,361 | +284.5% | 12,681 | +188.7% | 0.00% | – |
Q1 2023 | $33,906 | +3290.6% | 4,392 | +3358.3% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 127 | -56.2% | 0.00% | – |
Q2 2022 | $2,000 | -96.1% | 290 | -94.9% | 0.00% | – |
Q1 2022 | $51,000 | -60.8% | 5,703 | -39.6% | 0.00% | – |
Q4 2021 | $130,000 | -77.8% | 9,438 | -82.8% | 0.00% | – |
Q3 2021 | $585,000 | +19400.0% | 54,878 | +18192.7% | 0.00% | – |
Q2 2021 | $3,000 | -25.0% | 300 | -18.0% | 0.00% | – |
Q1 2021 | $4,000 | +300.0% | 366 | +446.3% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 67 | +6.3% | 0.00% | – |
Q3 2020 | $1,000 | – | 63 | +142.3% | 0.00% | – |
Q2 2020 | $0 | – | 26 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 26 | -93.5% | 0.00% | – |
Q2 2019 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | -96.6% | 400 | -96.4% | 0.00% | – |
Q1 2018 | $88,000 | -25.4% | 10,993 | +4.0% | 0.00% | – |
Q4 2017 | $118,000 | – | 10,569 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,199,011 | $24,629,000 | 3.99% |
BVF INC/IL | 675,759 | $7,569,000 | 0.91% |
Orbimed Advisors | 3,298,516 | $36,943,000 | 0.47% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 913,100 | $10,227,000 | 0.40% |
TIGER MANAGEMENT L.L.C. | 162,728 | $1,823,000 | 0.28% |
Rock Springs Capital Management LP | 150,000 | $1,680,000 | 0.08% |
Sowell Financial Services LLC | 15,714 | $168,000 | 0.04% |
Spark Investment Management LLC | 16,600 | $185,000 | 0.01% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 10,000 | $112,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 38,750 | $434,000 | 0.01% |